文献速递消化系统肿瘤

微小RNA在胰腺癌诊断、治疗与预后评估中的应用

[Diagnosis, treatment and prognosis evaluation of pancreatic cancer by microRNA].
PubMed 文献 · Zhonghua Zhong Liu Za Zhi · 2020-01-01

本文综述了微小RNA(miRNA)在胰腺癌中的异常表达及其与肿瘤发生发展的密切关系。研究表明miRNA有潜力成为胰腺癌新型诊断、预后预测生物标志物及治疗靶点,但实际应用推广尚存困难,作用机制仍需深入研究。

要点

  • miRNA在胰腺癌中广泛异常表达,与肿瘤发生发展密切相关。
  • miRNA有潜力成为胰腺癌诊断、预后预测生物标志物及治疗靶点。
  • miRNA实际应用推广尚存困难,作用机制有待深入研究。

核心结论

  • miRNA在胰腺癌中存在异常表达且与发生发展密切相关,具有成为新型诊断、预后预测生物标志物及治疗靶点的潜能。

研究设计与样本

  • 本文为综述,围绕miRNA在胰腺癌诊断、治疗和预后评价中的研究进行汇总。

主要发现

  • 相关研究初步显示miRNA在胰腺癌的诊断、治疗和预后评价中具有应用价值。
  • miRNA在胰腺癌中广泛异常表达,与胰腺癌的发生、发展密切相关。

临床怎么用

  • miRNA有潜力作为胰腺癌诊断、预后预测生物标志物及治疗靶点,但实际应用推广尚存困难。

局限性

  • miRNA对胰腺癌的作用机制还有待深入研究。
  • miRNA在胰腺癌实际应用推广尚存在一些困难。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Pancreatic cancer, with the characteristics of insidious onset, easy metastasis, chemotherapy resistance and poor prognosis, is a common malignant tumor of the digestive system. Early diagnosis and treatment of pancreatic cancer is one of the major problems in modern medicine, and there is an urgent need to find new diagnostic, prognostic biomarkers and therapeutic targets. MicroRNA (miRNA) is a small non-coding RNA which can regulate the expression of various genes. miRNAs have wide abnormal expressions in pancreatic cancer, and are closely related to the occurrence and development of pancreatic cancer. Thereby, miRNAs have the potential to become new diagnostic, prognostic and predictive biomarkers and therapeutic targets of pancreatic cancer. Many studies have initially shown that miRNAs have the application value in the diagnosis, treatment and prognosis evaluation of pancreatic cancer, but there are still some difficulties in the practical application and promotion. The mechanisms of miRNAs in pancreatic cancer remain to be further studied. 胰腺癌是常见的消化道恶性肿瘤,具有起病隐匿、易转移、化疗耐药和预后差等特点,胰腺癌的早期诊断和治疗是现代医学的一大难题,迫切需要寻找新的诊断、预后生物标志物及治疗靶点。微小RNA(miRNA)是一种调节多种基因表达的小分子非编码RNA,在胰腺癌中存在异常表达,且与胰腺癌的发生、发展密切相关,因此具有成为新型诊断、预后预测生物标志物及治疗靶点的潜能。相关研究初步显示出miRNA在胰腺癌的诊断、治疗和预后评价中具有应用价值,但目前实际应用推广尚存在一些困难,miRNA对胰腺癌的作用机制还有待深入研究。.

来源:Zhonghua Zhong Liu Za Zhi,查看原文。版权归原作者所有。

引用

  1. Ren H, Wang CF. [Diagnosis, treatment and prognosis evaluation of pancreatic cancer by microRNA]. Zhonghua Zhong Liu Za Zhi. 2020. PMID: 33256299. doi:10.3760/cma.j.cn112152-20190313-00152

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。